Position in SNDX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$11,946,861
+$6,120,714 QoQ
Shares Held
546,517
+119.1% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#45
of 242 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. SNDX ranks #14 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in SNDX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,946,861 | 546,517 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $5,826,147 | 249,407 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,628,329 | 125,099 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,389,536 | 155,316 | Shares | Sole | 2025-11-13 | |
| 2024-06-30 | $1,700,889 | 82,849 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,640,742 | 237,006 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,763,251 | 174,144 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,328,565 | 91,499 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $5,590,026 | 267,082 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,851,886 | 182,381 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,557,713 | 179,085 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,653,336 | 68,803 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,979,178 | 206,818 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,646,932 | 209,835 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,396,431 | 200,842 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,901,898 | 204,181 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,537,037 | 206,001 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,742,230 | 122,640 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,453,272 | 110,309 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $816,065 | 55,289 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,029,619 | 69,475 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $762,140 | 69,475 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||